The decision follows the initial approval granted in September 2023, which covered patients aged five years and above.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has dosed the first subject in the YOSEMITE Phase 3 clinical trial of zodasiran, the company’s investigational RNA interference ...

In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines.

Heart disease is often seen as a problem that only affects older adults, but more and more young people are being diagnosed ...

What to Know About Managing Familial Hypercholesterolemia — A multipronged approach is needed for these patients to achieve adequate cholesterol lowering ...

Do you have high cholesterol? You're not alone — millions of adults in the United States face this common but serious issue. High cholesterol increases the risk of heart disease, ...

The firm is hoping to show that the RNAi drug can treat HoFH by reducing production of ANGPTL3, which regulates lipid and lipoprotein metabolism.

Eli Lilly & Co. has divulged relaxin receptor 1 (RXFP1; LGR7) agonists reported to be useful for the treatment of diabetes, stroke, atherosclerosis, pulmonary hypertension, chronic obstructive ...

Margie Junker, an expert in cardiovascular nutrition, has shared seven foods she eats for a healthy heart, as well as some ...

Cholesterol is a type of fat found in your blood, and while your body needs it to create healthy cells, having high cholesterol levels can increase your risk of heart disease ...

A weight loss expert said that this tasty and affordable vegetable is packed with fibre, antioxidants and anti-inflammatory ...

A 79p "superfood" could be instrumental in reducing cholesterol, according to a weight loss expert. This wallet-friendly ...